Subcutaneous Sumatriptan Relieved Migraine-Like Headache in Two Adolescents With Aseptic Meningitis

Authors

  • Sergey Prokhorov MD,

    1. From the Department of Pediatrics, Lincoln Medical and Mental Health Center, Bronx, New York, and Weill Medical College of Cornell University, New York, NY, USA.
    Search for more papers by this author
  • Shefali Khanna MD,

    1. From the Department of Pediatrics, Lincoln Medical and Mental Health Center, Bronx, New York, and Weill Medical College of Cornell University, New York, NY, USA.
    Search for more papers by this author
  • Deepthy Alapati MD,

    1. From the Department of Pediatrics, Lincoln Medical and Mental Health Center, Bronx, New York, and Weill Medical College of Cornell University, New York, NY, USA.
    Search for more papers by this author
  • Sai Lakshmi Pallimalli MD

    1. From the Department of Pediatrics, Lincoln Medical and Mental Health Center, Bronx, New York, and Weill Medical College of Cornell University, New York, NY, USA.
    Search for more papers by this author

  • Conflict of Interest: None

S. Prokhorov, Department of Pediatrics, Lincoln Medical and Mental Health Center, Bronx, New York, and Weill Medical College of Cornell University, New York, NY, USA.

Abstract

Sumatriptan was developed as an agent for the treatment of acute migraine. However, sumatriptan may alleviate not only migraine headache, but also headache of subarachnoid hemorrhage and meningitis. We report 2 patients whose migraine-like headache on presentation was relieved by subcutaneous sumatriptan. Later, both patients were diagnosed with aseptic meningitis.

Ancillary